Recombinant multi-species Nanog/NANOG protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Nanog/NANOG protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a DNA binding homeobox transcription factor involved in embryonic stem (ES) cell proliferation, renewal, and pluripotency. The encoded protein can block ES cell differentiation and can also autorepress its own expression in differentiating cells. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2015]
The Alternative Names of target: 2410002E02Rik,ENK,Homeobox protein NANOG,Homeobox transcription factor Nanog (hNanog),NANOG,Nanog,Stm1,ecat4

Target products collectionGo to Nanog/NANOG products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP12349-Ag-1/ GM-Tg-hg-IP12349-Ag-2 Human Nanog/NANOG protein Human
GM-Tg-rg-IP12349-Ag-1/ GM-Tg-rg-IP12349-Ag-2 Rat Nanog/NANOG protein Rat
GM-Tg-mg-IP12349-Ag-1/ GM-Tg-mg-IP12349-Ag-2 Mouse Nanog/NANOG protein Mouse
GM-Tg-cynog-IP12349-Ag-1/ GM-Tg-cynog-IP12349-Ag-2 Cynomolgus/Rhesus macaque Nanog/NANOG protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP12349-Ag-1/ GM-Tg-felg-IP12349-Ag-2 Feline Nanog/NANOG protein Feline
GM-Tg-cang-IP12349-Ag-1/ GM-Tg-cang-IP12349-Ag-2 Canine Nanog/NANOG protein Canine
GM-Tg-bovg-IP12349-Ag-1/ GM-Tg-bovg-IP12349-Ag-2 Bovine Nanog/NANOG protein Bovine
GM-Tg-equg-IP12349-Ag-1/ GM-Tg-equg-IP12349-Ag-2 Equine Nanog/NANOG protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP12349-Ag-1/ GM-Tg-hg-IP12349-Ag-2; GM-Tg-rg-IP12349-Ag-1/ GM-Tg-rg-IP12349-Ag-2;
GM-Tg-mg-IP12349-Ag-1/ GM-Tg-mg-IP12349-Ag-2; GM-Tg-cynog-IP12349-Ag-1/ GM-Tg-cynog-IP12349-Ag-2;
GM-Tg-felg-IP12349-Ag-1/ GM-Tg-felg-IP12349-Ag-2; GM-Tg-cang-IP12349-Ag-1/ GM-Tg-cang-IP12349-Ag-2;
GM-Tg-bovg-IP12349-Ag-1/ GM-Tg-bovg-IP12349-Ag-2; GM-Tg-equg-IP12349-Ag-1/ GM-Tg-equg-IP12349-Ag-2
Products Name Nanog/NANOG protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Nanog/NANOG
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Nanog/NANOG protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.